Bioinformation · 2014 · 27 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyComputational Medicinal ChemistryDrug DesignDrug DiscoveryEnzyme InhibitionLead Compound DesignMolecular DockingProtein DockingProtein-ligand DockingVirtual ScreeningDocking ValidationDocking-based Drug DesignHigh-throughput Virtual ScreeningMolecular Docking AnalysisMolecular Docking Of InhibitorsMolecular Docking ValidationVirtual Screening Validation
The HBx protein in Hepatitis B Virus (HBV) is a potential target for anti-liver cancer molecules. Therefore, it is of interest to screen known natural compounds against the HBx protein using molecular docking. However, the structure of HBx is not yet known. Therefore, the predicted structure of HBx using threading in LOMET was used for docking against plant derived natural compounds (curcumin, oleanolic acid, resveratrol, bilobetin, luteoline, ellagic acid, betulinic acid and rutin) by Molegro Virtual Docker. The screening identified rutin with binding energy of -161.65 Kcal/mol. Thus, twenty derivatives of rutin were further designed and screened against HBx. These in silico experiments identified compounds rutin01 (-163.16 Kcal/mol) and rutin08 (- 165.76 Kcal/mol) for further consideration and downstream validation.
16
DrugBank 4.0: shedding new light on drug metabolism
Vivian Law, Craig Knox, Yannick Djoumbou-Feunang et al. · Nucleic Acids Research · 2013 · 2.1K citations · Full text
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox, Vivian Law, Timothy Jewison et al. · Nucleic Acids Research · 2010 · 1.9K citations · Full text